Artificial vascular graft migration into hollow viscus organs in

Background:To share our experience with hollow viscus migration of artificial vascular grafts (AVG) used for venous reconstruction of the right anterior sector in living donor liver transplantations (LDLT). Methods:Clinical, radiological, and endoscopic data of 13 right lobe LDLT patients (range: 26...

Full description

Bibliographic Details
Main Authors: Koc, C, Akbulut, S, Bilgic, Y, Otan, E, Sarici, B, Isik, B, Bayindir, Y, Kutlu, R, Jeng, LB, Yilmaz, S
Language:unknown
Published: 2020
Subjects:
Online Access:http://hdl.handle.net/11616/23642
Description
Summary:Background:To share our experience with hollow viscus migration of artificial vascular grafts (AVG) used for venous reconstruction of the right anterior sector in living donor liver transplantations (LDLT). Methods:Clinical, radiological, and endoscopic data of 13 right lobe LDLT patients (range: 26-67 years) with a diagnosis of postoperative AVG migration into adjacent hollow viscus were analyzed. Results:Biliary complications were detected in 12 patients. A median of four times endoscopic retrograde cholangiopancreatography (ERCP) procedures were performed in 11 patients prior to AVG migration diagnosis. A median of 2.5 times various percutaneous radiological interventional procedures were performed in eight patients prior to AVG migration diagnosis. The site of migration was the duodenum in eight patients, gastric antrum in four, and Roux limb in the remaining one patient. The migrated AVS were made of polytetrafluoroethylene (PTFE) in 10 patients and polyethylene terephthalate (Dacron) in three. The migrated AVGs were endoscopically removed in seven patients and surgically removed in six. Only one patient died due to sepsis unrelated to AVG migration. Conclusion:AVG migration into the adjacent hollow viscus following right lobe LDLT is a rare and serious complication. Repetitive ERCP, interventional radiological procedures, infection related to biliary leakage, and thrombosis of AVGs are among the possible risk factors. C1 [Koc, Cemalettin; Akbulut, Sami; Otan, Emrah; Sarici, Baris; Isik, Burak; Yilmaz, Sezai] Inonu Univ, Liver Transplant Inst, Elazig Yolu 10 Km, TR-44280 Malatya, Turkey. [Bilgic, Yilmaz] Inonu Univ, Fac Med, Dept Gastroenterol, Malatya, Turkey. [Bayindir, Yasar] Inonu Univ, Fac Med, Dept Infect Dis & Clin Microbiol, Malatya, Turkey. [Kutlu, Ramazan] Inonu Univ, Fac Med, Dept Radiol, Malatya, Turkey. [Jeng, Long-Bin] China Med Univ Hosp, Dept Surg, Taichung, Taiwan. [Jeng, Long-Bin] China Med Univ Hosp, Organ Transplant Ctr, Taichung, Taiwan.